Application of sanguinarine in inhibiting growth of multi-drug-resistant serratia marcescens
A Serratia marcescens, multi-drug resistance technology, applied in the field of medicine, to achieve the effect of solving the problem of drug resistance and infection, reducing the fatality rate, and wide application value
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0014] The present invention will be described in further detail below in conjunction with the examples. The embodiments are only used to explain the present invention, not to limit the protection scope of the present invention.
[0015] 1. Drug susceptibility test of Serratia marcescens
[0016] The present invention takes multiple strains of human Serratia marcescens (strain samples are taken from Ningbo Women and Children's Hospital) as starting strains, and selects ampicillin, ampicillin / sulbactam, cefazolin, cefotetan, ceftriaxone, ceftazidime , piperacillin / tazobactam, co-trimoxazole, cefepime, aztreonam, gentamicin, ertapenem, imipenem, tobramycin, amikacin, ciproterone 18 kinds of commonly used antibiotics including floxacin, nitrofurantoin and levofloxacin were tested.
[0017] Pick the pure colonies cultured for 16 hours and dissolve them evenly in 3 mL of sterile saline, and adjust their turbidity to be equal to that of a 0.5 McFarland turbidimetric tube. Antibio...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com